Literature DB >> 20032057

Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions.

Xun Zhang1, Kimberley Rice, Yingying Wang, Wendy Chen, Ying Zhong, Yuki Nakayama, Yunli Zhou, Anne Klibanski.   

Abstract

Maternally expressed gene 3 (MEG3) is an imprinted gene highly expressed in the human pituitary. However, MEG3 expression is lost in human gonadotroph-derived pituitary adenomas and most human tumor cell lines. Expression of MEG3 in tumor cells results in growth suppression, p53 protein increase, and activation of p53 downstream targets. The MEG3 gene encodes a noncoding RNA of approximately 1700 nucleotides. There are 12 different MEG3 gene transcripts, generated by alternative splicing. They contain the common exons 1-3 and exons 8-10, but each uses one or more exons 4-7 in a different combination in the middle. MEG3 isoform expression patterns are tissue and cell type specific. Functionally, each isoform stimulates p53-mediated transactivation and suppresses tumor cell growth. We analyzed the secondary RNA folding structure of each MEG3 isoform, using the computer program mfold. All MEG3 RNA isoforms contain three distinct secondary folding motifs M1, M2, and M3. Deletion analysis showed that motifs M2 and M3 are important for p53 activation. Furthermore, a hybrid MEG3 RNA, containing a piece of artificially synthesized sequence different from the wild type but folding into a similar secondary structure, retained the functions of both p53 activation and growth suppression. These results support the hypothesis that a proper folding structure of the MEG3 RNA molecule is critical for its biological functions. This study establishes for the first time the structure-function relationship of a large noncoding RNA and provides a first look into the molecular mechanisms of the biological functions of a large noncoding RNA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20032057      PMCID: PMC2840681          DOI: 10.1210/en.2009-0657

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Epigenetic analysis of the Dlk1-Gtl2 imprinted domain on mouse chromosome 12: implications for imprinting control from comparison with Igf2-H19.

Authors:  Shuji Takada; Martina Paulsen; Maxine Tevendale; Chen-En Tsai; Gavin Kelsey; Bruce M Cattanach; Anne C Ferguson-Smith
Journal:  Hum Mol Genet       Date:  2002-01-01       Impact factor: 6.150

Review 2.  The chemical repertoire of natural ribozymes.

Authors:  Jennifer A Doudna; Thomas R Cech
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

3.  Mfold web server for nucleic acid folding and hybridization prediction.

Authors:  Michael Zuker
Journal:  Nucleic Acids Res       Date:  2003-07-01       Impact factor: 16.971

4.  Delta-like and gtl2 are reciprocally expressed, differentially methylated linked imprinted genes on mouse chromosome 12.

Authors:  S Takada; M Tevendale; J Baker; P Georgiades; E Campbell; T Freeman; M H Johnson; M Paulsen; A C Ferguson-Smith
Journal:  Curr Biol       Date:  2000-09-21       Impact factor: 10.834

5.  DNA damage-induced inhibition of securin expression is mediated by p53.

Authors:  Yunli Zhou; Kshama R Mehta; Andrew P Choi; Staci Scolavino; Xun Zhang
Journal:  J Biol Chem       Date:  2002-10-25       Impact factor: 5.157

6.  Alternative splicing and imprinting control of the Meg3/Gtl2-Dlk1 locus in mouse embryos.

Authors:  Sylvie Croteau; Marie-Claude Charron; Keith E Latham; Anna K Naumova
Journal:  Mamm Genome       Date:  2003-04       Impact factor: 2.957

7.  Loss of expression of GADD45 gamma, a growth inhibitory gene, in human pituitary adenomas: implications for tumorigenesis.

Authors:  Xun Zhang; Huiping Sun; Daniel C Danila; Stacey R Johnson; Yunli Zhou; Brooke Swearingen; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

8.  Identification of an imprinted gene, Meg3/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q.

Authors:  N Miyoshi; H Wagatsuma; S Wakana; T Shiroishi; M Nomura; K Aisaka; T Kohda; M A Surani; T Kaneko-Ishino; F Ishino
Journal:  Genes Cells       Date:  2000-03       Impact factor: 1.891

9.  Distinct RNA motifs are important for coactivation of steroid hormone receptors by steroid receptor RNA activator (SRA).

Authors:  Rainer B Lanz; Bahram Razani; Aaron D Goldberg; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-20       Impact factor: 11.205

10.  A pituitary-derived MEG3 isoform functions as a growth suppressor in tumor cells.

Authors:  Xun Zhang; Yunli Zhou; Kshama R Mehta; Daniel C Danila; Staci Scolavino; Stacey R Johnson; Anne Klibanski
Journal:  J Clin Endocrinol Metab       Date:  2003-11       Impact factor: 5.958

View more
  146 in total

Review 1.  Long non-coding RNAs and cancer: a new frontier of translational research?

Authors:  R Spizzo; M I Almeida; A Colombatti; G A Calin
Journal:  Oncogene       Date:  2012-01-23       Impact factor: 9.867

Review 2.  Large non-coding RNAs: missing links in cancer?

Authors:  Maite Huarte; John L Rinn
Journal:  Hum Mol Genet       Date:  2010-08-20       Impact factor: 6.150

Review 3.  Pathogenesis of pituitary tumors.

Authors:  Shlomo Melmed
Journal:  Nat Rev Endocrinol       Date:  2011-03-22       Impact factor: 43.330

4.  Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.

Authors:  Lei Nie; Hsing-Ju Wu; Jung-Mao Hsu; Shih-Shin Chang; Adam M Labaff; Chia-Wei Li; Yan Wang; Jennifer L Hsu; Mien-Chie Hung
Journal:  Am J Transl Res       Date:  2012-04-08       Impact factor: 4.060

5.  Anterior pituitary adenomas: inherited syndromes, novel genes and molecular pathways.

Authors:  Paraskevi Xekouki; Monalisa Azevedo; Constantine A Stratakis
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

6.  Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions.

Authors:  Yuan Shen; Shanshan Liu; Jiao Fan; Yinghua Jin; Baolei Tian; Xiaofei Zheng; Hanjiang Fu
Journal:  EMBO Rep       Date:  2017-03-06       Impact factor: 8.807

Review 7.  LncRNAs: macromolecules with big roles in neurobiology and neurological diseases.

Authors:  Ye Chen; Jun Zhou
Journal:  Metab Brain Dis       Date:  2017-02-04       Impact factor: 3.584

8.  The lncRNA RMEL3 protects immortalized cells from serum withdrawal-induced growth arrest and promotes melanoma cell proliferation and tumor growth.

Authors:  Cibele Cardoso; Rodolfo B Serafim; Akinori Kawakami; Cristiano Gonçalves Pereira; Jason Roszik; Valeria Valente; Vinicius L Vazquez; David E Fisher; Enilza M Espreafico
Journal:  Pigment Cell Melanoma Res       Date:  2018-12-16       Impact factor: 4.693

Review 9.  A critical overview of long non-coding RNA in glioma etiology 2016: an update.

Authors:  Yuan-Feng Gao; Zhi-Bin Wang; Tao Zhu; Chen-Xue Mao; Xiao-Yuan Mao; Ling Li; Ji-Ye Yin; Hong-Hao Zhou; Zhao-Qian Liu
Journal:  Tumour Biol       Date:  2016-09-15

10.  Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line.

Authors:  Paweena Chunharojrith; Yuki Nakayama; Xiaobing Jiang; Rachel E Kery; Jun Ma; Cristine S De La Hoz Ulloa; Xun Zhang; Yunli Zhou; Anne Klibanski
Journal:  Mol Cell Endocrinol       Date:  2015-08-15       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.